Published in Genesis on May 01, 2010
Myb proteins: angels and demons in normal and transformed cells. Front Biosci (Landmark Ed) (2011) 0.96
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. Blood Cancer J (2012) 0.76
A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell (1991) 6.14
Critical functions for c-Myb at three checkpoints during thymocyte development. Nat Immunol (2004) 1.91
c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity (2005) 1.87
Coordination of erythropoiesis by the transcription factor c-Myb. Blood (2006) 1.52
Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci U S A (2009) 1.48
Requirement of c-myb in T cell development and in mature T cell function. Proc Natl Acad Sci U S A (2004) 1.32
c-Myb is required for pro-B cell differentiation. J Immunol (2009) 1.10
Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences. Oncogene (1989) 1.08
Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities. Mol Cell Biol (2008) 1.04
Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb. Mol Cell Biol (2003) 1.03
Identification of two translational products for c-myb. Oncogene (1989) 1.02
Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis. EMBO J (2009) 1.00
Overexpression of an alternatively spliced form of c-Myb results in increases in transactivation and transforms avian myelomonoblasts. J Virol (1998) 0.87
Cloning of murine G1RP, a novel gene related to Drosophila melanogaster g1. Gene (2000) 0.84
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell (2005) 3.56
Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation. Am J Gastroenterol (2007) 2.36
Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass. J Clin Gastroenterol (2007) 1.59
Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol Cell Biol (2002) 1.58
JAKs, STATs and Src kinases in hematopoiesis. Oncogene (2002) 1.56
Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo. J Cell Biol (2006) 1.52
Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci U S A (2009) 1.48
Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis. Cancer Res (2005) 1.46
Is referral to the neuro-oncology MDT safe? Br J Neurosurg (2012) 1.42
Increased angiogenesis in Cdk4(R24C/R24C):Apc(+/Min) intestinal tumors. Cell Cycle (2010) 1.40
Eye trauma: primary care for general physicians. Natl Med J India (2002) 1.39
Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Res (2005) 1.37
Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol (2008) 1.36
Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. Genes Cancer (2010) 1.34
Requirement of c-myb in T cell development and in mature T cell function. Proc Natl Acad Sci U S A (2004) 1.32
A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance. Proc Natl Acad Sci U S A (2005) 1.30
JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A (2002) 1.22
Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract (2002) 1.21
Long-term outcomes of acute gastric variceal bleeding in 48 patients following treatment with cyanoacrylate. Dig Dis Sci (2007) 1.17
Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab. Can J Ophthalmol (2007) 1.16
Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex (2011) 1.09
Effect of ON 01910.Na, an anticancer mitotic inhibitor, on cell-cycle progression correlates with RanGAP1 hyperphosphorylation. Cancer Res (2011) 1.08
CDK4: A Key Player in the Cell Cycle, Development, and Cancer. Genes Cancer (2012) 1.07
A decision support system to facilitate management of patients with acute gastrointestinal bleeding. Artif Intell Med (2007) 1.06
Destabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML). Genes Cancer (2010) 1.05
JLP associates with kinesin light chain 1 through a novel leucine zipper-like domain. J Biol Chem (2005) 1.03
Neural respiratory drive as a physiological biomarker to monitor change during acute exacerbations of COPD. Thorax (2011) 1.03
Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb. Mol Cell Biol (2003) 1.03
Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol (2008) 1.02
Prospective randomized trial of EUS versus ERCP-guided common bile duct stone removal: an interim report (with video). Gastrointest Endosc (2009) 0.98
Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents. J Med Chem (2007) 0.98
Design, synthesis and evaluation of (E)-alpha-benzylthio chalcones as novel inhibitors of BCR-ABL kinase. Bioorg Med Chem (2010) 0.97
An in vivo functional screen uncovers miR-150-mediated regulation of hematopoietic injury response. Cell Rep (2012) 0.97
Osteoblastic bone flare on F18-FDG PET in non-small cell lung cancer (NSCLC) patients receiving bevacizumab in addition to standard chemotherapy. J Thorac Oncol (2009) 0.96
Comparison of scleral buckling with combined scleral buckling and pars plana vitrectomy in the management of rhegmatogenous retinal detachment with unseen retinal breaks. Clin Experiment Ophthalmol (2003) 0.95
Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer. Hepatology (2011) 0.95
Epigenetic silencing of beta-spectrin, a TGF-beta signaling/scaffolding protein in a human cancer stem cell disorder: Beckwith-Wiedemann syndrome. J Biol Chem (2010) 0.95
The practice of evidence-based medicine (EBM) in gastroenterology: discrepancies between EBM familiarity and EBM competency. Therap Adv Gastroenterol (2011) 0.94
Radiation protection by a new chemical entity, Ex-Rad: efficacy and mechanisms. Radiat Res (2009) 0.92
A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans. Gastroenterology (2012) 0.92
Submucosal injection of 0.4% hydroxypropyl methylcellulose facilitates endoscopic mucosal resection of early gastrointestinal tumors. J Clin Gastroenterol (2010) 0.91
Myb permits multilineage airway epithelial cell differentiation. Stem Cells (2014) 0.90
JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry (2005) 0.88
Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Bioorg Med Chem (2008) 0.87
Regulation of neurite outgrowth by interactions between the scaffolding protein, JNK-associated leucine zipper protein, and neuronal growth-associated protein superior cervical ganglia clone 10. J Biol Chem (2009) 0.87
Lung tumourigenesis in a conditional Cul4A transgenic mouse model. J Pathol (2014) 0.86
Transforming pathways activated by the v-Abl tyrosine kinase. Oncogene (2002) 0.86
Gastrointestinal stromal tumor in association with pyogenic liver abscess. Gastroenterol Hepatol (N Y) (2008) 0.86
A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema. J Ocul Pharmacol Ther (2004) 0.86
Novel coumarin-3-(N-aryl)carboxamides arrest breast cancer cell growth by inhibiting ErbB-2 and ERK1. Bioorg Med Chem (2005) 0.85
A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition. Genes Cancer (2010) 0.85
Inhibition of tumor angiogenesis in vivo by a monoclonal antibody targeted to domain 5 of high molecular weight kininogen. Blood (2004) 0.85
Diagnosis of arthritis through fuzzy inference system. J Med Syst (2010) 0.84
Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. J Cell Biochem (2006) 0.84
Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein. Neoplasia (2011) 0.84
Does position affect uroflowmetry parameters in women? Urol Int (2008) 0.83
Cameron ulcers: an atypical source for a massive upper gastrointestinal bleed. World J Gastroenterol (2012) 0.83
B-myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development. Proc Natl Acad Sci U S A (2014) 0.83
Metabolism of the polynuclear sulfur heterocycle benzo[b]phenanthro[2,3-d]thiophene by rodent liver microsomes: evidence for multiple pathways in the bioactivation of benzo[b]phenanthro[2,3-d]thiophene. Chem Res Toxicol (2003) 0.83
Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity. Bioorg Med Chem Lett (2004) 0.83
Commentary: Reaching a milestone in diagnosing coeliac disease. BMJ (2007) 0.83
Inhibition of actin polymerization decreases osteogeneic differentiation of mesenchymal stem cells through p38 MAPK pathway. J Biomed Sci (2013) 0.83
Choroidal tuberculoma in miliary tuberculosis. Retina (2003) 0.82
Provocation of bleeding during endoscopy in patients with recurrent acute lower gastrointestinal bleeding. Gastroenterol Hepatol (N Y) (2007) 0.82
A comparison of the consensus and clinical definitions of pancreatitis with a proposal to redefine post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas (2010) 0.82
Integrated pharmacokinetic-driven approach to screen candidate anticancer drugs for brain tumor chemotherapy. AAPS J (2012) 0.82
Targeted inhibition of kinases in cancer therapy. Mt Sinai J Med (2010) 0.82
Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev (2012) 0.81
Requirement of Cdk4 for v-Ha-ras-Induced Breast Tumorigenesis and Activation of the v-ras-Induced Senescence Program by the R24C Mutation. Genes Cancer (2010) 0.81
Mechanisms associated with IL-6-induced up-regulation of Jak3 and its role in monocytic differentiation. Blood (2004) 0.81
Impaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout mice. Cell Cycle (2012) 0.81
Differential staining with indocyanine green and trypan blue dye. Indian J Ophthalmol (2004) 0.80
The role of lipids in the development of diabetic microvascular complications: implications for therapy. Am J Cardiovasc Drugs (2003) 0.80
A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer. J Thorac Oncol (2010) 0.80
Preclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor models. Mol Cancer Ther (2014) 0.80
c-Myc is essential but not sufficient for c-Myb-mediated block of granulocytic differentiation. J Biol Chem (2003) 0.80
Comparative evaluation of oral fluorescein angiography using the confocal scanning laser ophthalmoscope and digital fundus camera with intravenous fluorescein angiography using the digital fundus camera. Clin Experiment Ophthalmol (2006) 0.80
Laser conjunctivoplasty: a new technique for correction of mild medial ectropion. Orbit (2003) 0.79
Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells. Blood (2002) 0.79
Amelia-meromelia sequence with atrial septal defect-a rare occurrence. Fetal Pediatr Pathol (2013) 0.79
Preclinical pharmacokinetic and pharmacodynamic evaluation of novel anticancer agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for brain tumor chemotherapy. Pharm Res (2012) 0.79
p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts. Cancer Res (2007) 0.79
A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity. J Clin Gastroenterol (2008) 0.79
Cooperativity of Cdk4R24C and Ras in melanoma development. Cell Cycle (2010) 0.79
Diaryl naphthyl methanes a novel class of anti-implantation agents. Bioorg Med Chem (2004) 0.79
Endoscopic ultrasound facilitates histological diagnosis of renal cell cancer. J Endourol (2008) 0.78
EUS-guided percutaneous endoscopic gastrostomy for enteral feeding tube placement. Gastrointest Endosc (2008) 0.78
Activation of the Jak3 pathway and myeloid differentiation. Leuk Lymphoma (2005) 0.78
(Z)-1-aryl-3-arylamino-2-propen-1-ones, highly active stimulators of tubulin polymerization: synthesis, structure-activity relationship (SAR), tubulin polymerization, and cell growth inhibition studies. J Med Chem (2012) 0.77
Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma. Clin Cancer Res (2012) 0.77
ON01210.Na (Ex-RAD®) mitigates radiation damage through activation of the AKT pathway. PLoS One (2013) 0.77